Your browser doesn't support javascript.
loading
Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab.
Fuchs, Charles S; Tabernero, Josep; Tomásek, Jirí; Chau, Ian; Melichar, Bohuslav; Safran, Howard; Tehfe, Mustapha A; Filip, Dumitru; Topuzov, Eldar; Schlittler, Luis; Udrea, Anghel Adrian; Campbell, William; Brincat, Stephen; Emig, Michael; Melemed, Symantha A; Hozak, Rebecca R; Ferry, David; Caldwell, C William; Ajani, Jaffer A.
Afiliación
  • Fuchs CS; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA.
  • Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona 08035, Spain.
  • Tomásek J; Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno 656 53, Czech Republic.
  • Chau I; Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, UK.
  • Melichar B; Onkologicka klinika, Lekarska fakulta Univerzity Palackeho a Fakultni nemocnice, I.P. Pavlova, 6, Olomouc 779 00, Czech Republic.
  • Safran H; Brown University Oncology Research Group, 164 Summit Avenue, Fain 3, Providence, Rhode Island 02906, USA.
  • Tehfe MA; Centre Hospitalier de Montréal, 1560 Sherbrooke East St, Montreal, Quebec H2L4M1, Canada.
  • Filip D; Spitalul Judetean de Urgenta, Strada George Cosbuc 31, Baia Mare 430031, Romania.
  • Topuzov E; State Budgetary Educational Institution of Higher Professional Education (SBEIHPE), Northwest State Medical University na II Mechnikov, Ministry of Healthcare of the Russian Federation, Russia.
  • Schlittler L; Hospital da Cida de Passo Fundo, Rua Tiradentes, 295 Centro, Passo Fundo, 99010-260, Brazil.
  • Udrea AA; Medisprof SRL, P-ta 1 Mai Nr 3, Cluj 400058, Romania.
  • Campbell W; Hospital Herrera Llerandi, 6 Avenida, Guatemala City, Guatemala.
  • Brincat S; Sir Anthony Mamo Oncology Centre, Msida, Malta.
  • Emig M; Lilly Deutschland GmbH, Werner-Reimers-Straße 2, Bad Homburg vor der Höhe 61352, Germany.
  • Melemed SA; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA.
  • Hozak RR; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA.
  • Ferry D; Eli Lilly and Company, 440 Route 22 East, Bridgewater, New Jersey 08807, USA.
  • Caldwell CW; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA.
  • Ajani JA; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 426, Houston, Texas 77030, USA.
Br J Cancer ; 115(8): 974-982, 2016 10 11.
Article en En | MEDLINE | ID: mdl-27623234
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma / Inhibidores de la Angiogénesis / Receptores de Factores de Crecimiento Endotelial Vascular / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Factores de Crecimiento Endotelial Vascular / Anticuerpos Monoclonales / Proteínas de Neoplasias / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma / Inhibidores de la Angiogénesis / Receptores de Factores de Crecimiento Endotelial Vascular / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Factores de Crecimiento Endotelial Vascular / Anticuerpos Monoclonales / Proteínas de Neoplasias / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos